Home > NRC Library > ADAMS Public Documents

Amend 4 to License 20-19976-01G for Enzyme Ctr,amending license in entirety.

Accession Number: ML20148B588

Date Released: Monday, October 28, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20148B609 - Forwards Amend 4,renewing License 20-19976-01G. (2 page(s), 6/4/1987)
• ML20148B625 - Ack receipt of application for renewal of License 20-19976-01G.Application deemed timely filed & license will not expire until final NRC action taken. (1 page(s), 4/20/1987)
• ML20148B681 - Application for renewal of License 20-19976-01G,authorizing distribution of in vitro diagnostic kits,containing I-125, to persons generally licensed per 10CFR31.11.Fee paid. (3 page(s), 3/30/1987)
• ML20148B720 - Application for amend to License 20-19976-01G,authorizing distribution of methotrexate radioassay I-125 kit to persons or organizations specifically licensed by NRC or Agreement States.W/encl.Fee paid. (2 page(s), 8/13/1982)
• ML20148B768 - Application for amend to License 20-19976-02,relocating new quarters at listed address.Plans of facility encl.Fee paid. (6 page(s), 2/3/1983)
• ML20148B915 - Notifies of reorganization in corporate structure & requests advice on need for amends to licenses 20-19976-01G & 20-19976-02.Reorganization involves disolution of original Enzyme Ctr,Inc & creation of new ctr.Fee paid. (2 page(s), 5/12/1986)